Search Results - "Cheung, Jeanne"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1
  2. 2

    Autoimmunity linked protein phosphatase PTPN22 as a target for cancer immunotherapy by Cubas, Rafael, Khan, Zia, Gong, Qian, Moskalenko, Marina, Xiong, Huizhong, Ou, Qinglin, Pai, Christine, Rodriguez, Ryan, Cheung, Jeanne, Chan, Andrew C

    Published in Journal for immunotherapy of cancer (01-10-2020)
    “…BackgroundCancer immunotherapy has evolved from interferon-alpha (IFNα) and interleukin-2 in the 1980s to CTLA-4 and PD-1/PD-L1 checkpoint inhibitors (CPIs),…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Role of PD-1 during effector CD8 T cell differentiation by Ahn, Eunseon, Araki, Koichi, Hashimoto, Masao, Li, Weiyan, Riley, James L., Cheung, Jeanne, Sharpe, Arlene H., Freeman, Gordon J., Irving, Bryan A., Ahmed, Rafi

    “…PD-1 (programmed cell death-1) is the central inhibitory receptor regulating CD8 T cell exhaustion during chronic viral infection and cancer. Interestingly,…”
    Get full text
    Journal Article
  5. 5

    T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition by Hui, Enfu, Cheung, Jeanne, Zhu, Jing, Su, Xiaolei, Taylor, Marcus J., Wallweber, Heidi A., Sasmal, Dibyendu K., Huang, Jun, Kim, Jeong M., Mellman, Ira, Vale, Ronald D.

    “…Programmed cell death–1 (PD-1) is a coinhibitory receptor that suppresses T cell activation and is an important cancer immunotherapy target. Upon activation by…”
    Get full text
    Journal Article
  6. 6

    MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint Blockade by Ebert, Peter J.R., Cheung, Jeanne, Yang, Yagai, McNamara, Erin, Hong, Rebecca, Moskalenko, Marina, Gould, Stephen E., Maecker, Heather, Irving, Bryan A., Kim, Jeong M., Belvin, Marcia, Mellman, Ira

    Published in Immunity (Cambridge, Mass.) (15-03-2016)
    “…Targeted inhibition of mitogen-activated protein kinase (MAPK) kinase (MEK) can induce regression of tumors bearing activating mutations in the Ras pathway but…”
    Get full text
    Journal Article
  7. 7

    PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer by Oh, Soyoung A, Wu, Dai-Chen, Cheung, Jeanne, Navarro, Armando, Xiong, Huizhong, Cubas, Rafael, Totpal, Klara, Chiu, Henry, Wu, Yan, Comps-Agrar, Laetitia, Leader, Andrew M, Merad, Miriam, Roose-Germa, Merone, Warming, Soren, Yan, Minhong, Kim, Jeong M, Rutz, Sascha, Mellman, Ira

    Published in Nature cancer (01-07-2020)
    “…Inhibiting the programmed death-1 (PD-1) pathway is one of the most effective approaches to cancer immunotherapy, but its mechanistic basis remains…”
    Get full text
    Journal Article
  8. 8

    Chemotherapy Combines Effectively with Anti-PD-L1 Treatment and Can Augment Antitumor Responses by Cubas, Rafael, Moskalenko, Marina, Cheung, Jeanne, Yang, Michelle, McNamara, Erin, Xiong, Huizhong, Hoves, Sabine, Ries, Carola H, Kim, Jeong, Gould, Stephen

    Published in The Journal of immunology (1950) (15-10-2018)
    “…Immunotherapy with checkpoint inhibitors has proved to be highly effective, with durable responses in a subset of patients. Given their encouraging clinical…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Abstract 4898: Effects of chemotherapeutic agents on the tumor immune microenvironment by Belvin, Marcia P., Luoh, Shiuh-Ming, Cheung, Jeanne, McNamara, Erin, Cubas, Rafael, Kim, Jeong

    Published in Cancer research (Chicago, Ill.) (15-07-2016)
    “…Abstract Immunotherapeutic agents have shown dramatic success in oncology in recent years and several have been approved in melanoma and lung cancer. One…”
    Get full text
    Journal Article
  11. 11

    IL-25 Induces IL-4, IL-5, and IL-13 and Th2-Associated Pathologies In Vivo by Fort, Madeline M., Cheung, Jeanne, Yen, David, Li, Joana, Zurawski, Sandra M., Lo, Sylvia, Menon, Satish, Clifford, Teresa, Hunte, Brisdell, Lesley, Robin, Muchamuel, Tony, Hurst, Stephen D., Zurawski, Gerard, Leach, Michael W., Gorman, Daniel M., Rennick, Donna M.

    Published in Immunity (Cambridge, Mass.) (01-12-2001)
    “…We have characterized a cytokine produced by Th2 cells, designated as IL-25. Infusion of mice with IL-25 induced IL-4, IL-5, and IL-13 gene expression. The…”
    Get full text
    Journal Article
  12. 12

    Abstract 4905: Effects of MAPK pathway inhibitors in the tumor immune microenvironment by Belvin, Marcia P., Williams, Erin, Luoh, Shiuh-Ming, Cheung, Jeanne, Orr, Christine, Chan, Emily, Ebert, Peter, Mellman, Ira, Kim, Jeong, Merchant, Mark

    Published in Cancer research (Chicago, Ill.) (15-07-2016)
    “…Abstract Immunotherapeutic agents have shown great promise in the clinic in recent years and this has led to their approval as single agents or as immune…”
    Get full text
    Journal Article
  13. 13

    MAP kinase inhibitors stimulate T cell and anti-tumor activity in combination with blockade of the PD-L1/PD-1 interaction by Irving, Bryan A, Cheung, Jeanne, Yang, Yagai, Moskalenka, Marina, Kowanetz, Marcin, Maecker, Heather, Mellman, Ira

    Published in Journal for immunotherapy of cancer (07-11-2013)
    “…Pharmacological inhibition of the MAPK pathway with MEK or BRAF antagonists has proved successful in inducing regression of melanoma tumors bearing the…”
    Get full text
    Journal Article
  14. 14

    Masoprocol (nordihydroguaiaretic acid): a new antihyperglycemic agent isolated from the creosote bush ( Larrea tridentata) by Luo, Jian, Chuang, Tom, Cheung, Jeanne, Quan, Josephine, Tsai, Joyce, Sullivan, Cynthia, Hector, Richard F, Reed, Michael J, Meszaros, Karl, King, Steven R, Carlson, Thomas J, Reaven, Gerald M

    Published in European journal of pharmacology (03-04-1998)
    “…An ethnomedically-driven approach was used to evaluate the ability of a pure compound isolated from the creosote bush ( Larrea tridentata) to lower plasma…”
    Get full text
    Journal Article
  15. 15

    Novel terpenoid-type quinones isolated from Pycnanthus angolensis of potential utility in the treatment of type 2 diabetes by Luo, J, Cheung, J, Yevich, E M, Clark, J P, Tsai, J, Lapresca, P, Ubillas, R P, Fort, D M, Carlson, T J, Hector, R F, King, S R, Mendez, C D, Jolad, S D, Reaven, G M

    “…Using an ethnomedical-based drug discovery program, two previously unknown compounds (SP-18904 and SP-18905) from Pycnanthus angolensis were isolated that…”
    Get more information
    Journal Article
  16. 16
  17. 17
  18. 18